share_log

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Wilson Mark Andrew

SEC announcement ·  Dec 15, 2023 18:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more